Patent · US Active

Benzimidazoledihydrothiadiazinone derivatives as fructose-1,6-bisphosphatase inhibitors, and pharmaceutical compositions comprising same

US8232272B2 · kind B2 · utility

0Cited by

2References

26Claims

0Family size

Assignee

MERCK PATENT GESELLSCHAFT MIT BESHRANK TER HAFTUNG · DE

Inventors

Gerard Botton · Buc, FR
Caroline Leriche · Paris, FR
Annick Arbellot De Vacqueur · Arpajon, FR
Annick Audet · Leudeville, FR
Johannes Gleitz · Darmstadt, DE

Key dates

Filing date	Oct 13, 2008
Grant date	Jul 31, 2012
Priority date	—
Expiry date	Apr 21, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D417/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to novel benzimidazole-dihydrothiadiazinone derivatives as fructose-1,6-bisphosphatase inhibitors, to processes for the preparation thereof and to the use thereof in therapy, especially for the treatment of diabetes.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.